Literature DB >> 23488713

Federalizing medical campaigns against alcoholism and drug abuse.

Grischa Metlay1.   

Abstract

CONTEXT: The formation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the Special Action Office for Drug Abuse Prevention (SAODAP) in the early 1970s dramatically expanded scientific and medical efforts to control alcoholism and drug abuse in the United States.
METHODS: Drawing on a variety of primary, secondary, and archival sources, this article describes the creation and early years of these agencies.
FINDINGS: I show that while the agencies appeared at roughly the same time, their creation involved separate sets of issues and actors. In addition, I show that SAODAP received more money and resources, even though advocates for alcoholics mobilized a stronger lobbying campaign.
CONCLUSIONS: Two factors explain this discrepancy in money and resources: (1) alcoholism was framed as a public health problem, whereas drug abuse was drawn into broader debates about crime and social decline; and (2) alcohol programs relied on congressional support, whereas drug programs found champions at high levels of the Nixon administration. These political and cultural factors help explain why current programs for illegal drugs receive more federal support, despite alcohol's greater public health burden.
© 2013 Milbank Memorial Fund.

Entities:  

Mesh:

Year:  2013        PMID: 23488713      PMCID: PMC3607128          DOI: 10.1111/milq.12004

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  19 in total

1.  Civil commitment under the federal Narcotic Addict Rehabilitation Act.

Authors:  Richard Lindblad
Journal:  J Drug Issues       Date:  1988

2.  The Richmond County Medical Society's plan for the control of narcotic addiction.

Authors:  H BERGER
Journal:  N Y State J Med       Date:  1956-03-15

3.  A physician's blueprint for the management and prevention of narcotic addiction.

Authors:  H S HOWE
Journal:  N Y State J Med       Date:  1955-02-01

Review 4.  The Controlled Substances Act: how a "big tent" reform became a punitive drug law.

Authors:  David T Courtwright
Journal:  Drug Alcohol Depend       Date:  2004-10-05       Impact factor: 4.492

5.  Correction: actual causes of death in the United States, 2000.

Authors:  Ali H Mokdad; James S Marks; Donna F Stroup; Julie L Gerberding
Journal:  JAMA       Date:  2005-01-19       Impact factor: 56.272

6.  The natural history of a heroin epidemic.

Authors:  P H Hughes; N W Barker; G A Crawford; J H Jaffe
Journal:  Am J Public Health       Date:  1972-07       Impact factor: 9.308

7.  Profile of a heroin-addiction epidemic.

Authors:  R L DuPont
Journal:  N Engl J Med       Date:  1971-08-05       Impact factor: 91.245

8.  The prepared mind: Marie Nyswander, methadone maintenance, and the metabolic theory of addiction.

Authors:  D T Courtwright
Journal:  Addiction       Date:  1997-03       Impact factor: 6.526

9.  Disaggregating the burden of substance dependence in the United States.

Authors:  Bridget F Grant; Deborah A Dawson; Howard B Moss
Journal:  Alcohol Clin Exp Res       Date:  2011-02-11       Impact factor: 3.455

10.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE.

Authors:  V P DOLE; M NYSWANDER
Journal:  JAMA       Date:  1965-08-23       Impact factor: 56.272

View more
  3 in total

1.  Health: a dream from reality to the future.

Authors:  Chunsong Hu; Qinghua Wu
Journal:  Front Med       Date:  2016-04-18       Impact factor: 4.592

Review 2.  Creating a science of homelessness during the Reagan era.

Authors:  Marian Moser Jones
Journal:  Milbank Q       Date:  2015-03       Impact factor: 4.911

3.  Global Mortality Burden of Cirrhosis and Liver Cancer Attributable to Injection Drug Use, 1990-2016: An Age-Period-Cohort and Spatial Autocorrelation Analysis.

Authors:  Jin Yang; Yunquan Zhang; Lisha Luo; Runtang Meng; Chuanhua Yu
Journal:  Int J Environ Res Public Health       Date:  2018-01-22       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.